Skip to content
No-Antibiotics logo — Pioneering phage-based veterinary solutions for a healthier...

No-Antibiotics

Pioneering phage-based veterinary solutions for a healthier future in animal husbandry.

Founded 2017 Series A Total: $20.00M Biotechnology, Health Care +1

General Information

Company Name No-Antibiotics
Founded Year 2017
Industries Biotechnology, Health Care, AgriTech
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with No-Antibiotics. To contact No-Antibiotics, visit phagepharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does No-Antibiotics compare?

A PDF of No-Antibiotics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting No-Antibiotics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About No-Antibiotics

No-Antibiotics is a biotechnology startup that is pioneering phage-based veterinary solutions with the slogan "Pioneering phage-based veterinary solutions for a healthier future in animal husbandry." Founded in 2017, the company boasts a team of entrepreneurs and professors with extensive experience in China's insurance industry. No-Antibiotics specializes in creating phage and veterinary products targeting bacteria with high incidence and significant drug resistance in animal husbandry, covering a range of diseases including staphylococcus, salmonella, pseudomonas aeruginosa, respiratory actinomycetes, and bacterial diseases in aquatic animals. Last Investment: CNY20.00M Series A - No investment at 22 May 2019 Last Investment Investors: Qingsong Fund, Haidu Group, Milestone Capital China The company is committed to developing antibiotic alternative phage medicine solutions for bacterial diseases, contributing to the healthy development of China's agricultural and livestock industries. Operating in the biotechnology, healthcare, and agritech sectors, No-Antibiotics has garnered significant attention from investors, including Qingsong Fund, Haidu Group, and Milestone Capital China. With top-notch research and development capabilities and comprehensive R&D and production facilities, No-Antibiotics has positioned itself as a leader in phage technology industrialization. While the company's headquarters location is not specified, its focus on addressing critical issues in animal husbandry through innovative phage-based solutions demonstrates its potential to make a significant impact in the field.

Business keywords: phage-based solutions, veterinary, animal husbandry, drug development, antibiotic alternative, phage medicine, bacterial diseases, agricultural industry, livestock industry, production facilities, industrialization of phage technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A No CNY20.00M 3
Qingsong Fund, Haidu Group +1
22 May 2019

No-Antibiotics Alternatives & Competitors

View All Alternatives
No-Antibiotics vs
Alytix
Alytix Argentina

Inspired by what happens in nature

Pre-Seed
2 employees
Biotechnology, Health Care
No-Antibiotics vs

Safe and Residual Free Therapies for Animal Health

Corporate Round
39 employees
Biotechnology, AgriTech
No-Antibiotics vs
Zoetis
Zoetis United States

Nurturing our world and humankind by advancing care for animals

13444 employees
Biotechnology, Health Care

FAQ About No-Antibiotics

Pioneering phage-based veterinary solutions for a healthier future in animal husbandry.
No-Antibiotics was founded in 2017.
No-Antibiotics operates in Biotechnology, Health Care and AgriTech. Its work centres on phage-based solutions, veterinary, animal husbandry and drug development.
No-Antibiotics has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Series A.
Top alternatives and competitors to No-Antibiotics include Alytix, Mileutis Ltd., Zoetis, Prevtec microbia, Eli Lilly and Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
No-Antibiotics and Alytix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for No-Antibiotics, https://bouncewatch.com/company/no-antibiotics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout